Pfizer-BioNTech to test combined COVID, influenza vaccine Ruchika Sharma4 Nov 2022 3:40 PM ISTFrankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...
Biological E Corbevax safe, immunogenic in 5-18 age group Ruchika Sharma3 Nov 2022 4:30 PM ISTHyderabad: Biological E. Limited, a Hyderabad-based vaccine, and pharmaceutical company, today announced the publication of CORBEVAX COVID-19 vaccine...
CanSino Biologics inhalable COVID vaccine introduced in China Ruchika Sharma30 Oct 2022 1:30 PM ISTShanghai: In what is believed to be a world first, China's commerical capital of Shanghai this week introduced a new type of COVID-19 vaccine that is...
Pfizer expects to quadruple US COVID vaccine price to Rs 110- Rs130 per dose Ruchika Sharma23 Oct 2022 4:07 PM ISTReuters earlier on Thursday reported that Wall Street was expecting such price hikes due to weak demand for COVID vaccines, which meant vaccine makers...
Serum Institute stopped Covishield production in Dec 2021, says Poonawalla; claims there are no takers for booster shots as people are fed up Ruchika Sharma21 Oct 2022 12:30 PM ISTPune: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of...
USFDA grants emergency use nod for Novavax COVID vaccine,Adjuvanted as booster for adults Ruchika Sharma20 Oct 2022 5:46 PM ISTGaithersburg: Novavax, Inc. has announced that the company's COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA)...
Pfizer, BioNTech report positive early data from clinical trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in 18 years and older Ruchika Sharma16 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced early data from a Phase 2/3 clinical trial evaluating the safety, tolerability, and...
Biological E Corbevax offers better immunity as heterologous booster shot Ruchika Sharma14 Oct 2022 12:30 PM ISTCORBEVAX can be administered as a booster six months after two doses of COVAXIN or COVISHIELD for all adults.
Pfizer gets USFDA Emergency Use Authorization for bivalent omicron booster in children aged 5 through 11 years Ruchika Sharma13 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization...
84 Percent higher risk of cardiac-related death among males 18-39 years with MRNA vaccine: Analysis sparks fear against Pfizer, Moderna vaccine Roshni Dhar11 Oct 2022 6:30 PM ISTCreating a scare among the patients world-wide taking the mRNA-based COVID vaccine, a recent advisory has been released by the Florida Department of...
Setback: AstraZeneca nasal spray COVID vaccine fails in early trial Ruchika Sharma11 Oct 2022 3:33 PM ISTThe immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.
Health Bulletin 10/October/2022 Roshni Dhar10 Oct 2022 5:21 PM ISTHere are the Top health stories for the day:Maharashtra: Doctor booked for wrong sonography report after pregnant woman's deathA doctor running a...
